Prospective new biological therapies for rheumatoid arthritis.
about
Non-dietary methods in the treatment of celiac diseaseNanomedicine delivers promising treatments for rheumatoid arthritisHigh levels of metastasis-inducing S100A4 protein and treatment outcome in early rheumatoid arthritis: data from the PERAC cohort.Pattern and predictors of the initiation of biologic agents for the treatment of rheumatoid arthritis in the United States: an analysis using a large observational data bank.Golimumab.Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy.Active immunization to tumor necrosis factor-alpha is effective in treating chronic established inflammatory disease: a long-term study in a transgenic model of arthritis.Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5.Immune-mediated bile duct injury: The case of primary biliary cirrhosis.Interleukin 35 Synovial Fluid Levels Are Associated with Disease Activity of Rheumatoid Arthritis.Successful use of mRNA-nucleofection for overexpression of interleukin-10 in murine monocytes/macrophages for anti-inflammatory therapy in a murine model of autoimmune myocarditis.Certolizumab pegol: a new biologic targeting rheumatoid arthritis.Flow cytometric detection of p38 MAPK phosphorylation and intracellular cytokine expression in peripheral blood subpopulations from patients with autoimmune rheumatic diseases.The discovery of novel experimental therapies for inflammatory arthritis.siRNA therapy for cancer and non-lethal diseases such as arthritis and osteoporosis.J-LEAPS peptide and LEAPS dendritic cell vaccines.Cellular and molecular mechanisms of autoimmune disease.Designing micro- and nano-particles for treating rheumatoid arthritis.Tec family kinases in inflammation and disease.MicroRNAs in rheumatoid arthritis: potential role in diagnosis and therapy.Effects of immunosuppressive agents on Th17 cells involved in transplantation.Treat-to-target: a tailored treatment approach to rheumatoid arthritis.Therapeutic targets for rheumatoid arthritis: Progress and promises.Delayed Cytotoxic T Lymphocyte-Associated Protein 4-Immunoglobulin Treatment Reverses Ongoing Alloantibody Responses and Rescues Allografts From Acute RejectionCurrent perspectives on the role of IL-17 in autoimmune diseaseMonitoring drug and antidrug levels: a rational approach in rheumatoid arthritis patients treated with biologic agents who experience inadequate response while being on a stable biologic treatment.Effect of phenolic glycolipids from Mycobacterium kansasii on proinflammatory cytokine release. A structure-activity relationship study.Efficacy and Safety of Anti-Interleukin-20 Monoclonal Antibody in Patients With Rheumatoid Arthritis: A Randomized Phase IIa Trial.Myeloid-related protein activity in rheumatoid arthritis.IL-32 aggravates synovial inflammation and bone destruction and increases synovial natural killer cells in experimental arthritis models.Celiac disease: a challenging disease for pharmaceutical scientists.Combined treatment with hyaluronan inhibitor Pep-1 and a selective adenosine A2 receptor agonist reduces inflammation in experimental arthritis.NF-κB1/IKKε Gene Expression and Clinical Activity in Patients With Rheumatoid Arthritis.p38α regulates cytokine-induced IFNγ secretion via the Mnk1/eIF4E pathway in Th1 cells.Formulation and evaluation of poly(lactic-co-glycolic acid) microspheres loaded with an altered collagen type II peptide for the treatment of rheumatoid arthritis.Jatrorrhizine Hydrochloride Suppresses Proliferation, Migration, and Secretion of Synoviocytes In Vitro and Ameliorates Rat Models of Rheumatoid Arthritis In Vivo.Modeling Transcriptional Rewiring in Neutrophils Through the Course of Treated Juvenile Idiopathic Arthritis.Characterization of the anticollagen antibody response in a new model of chronic polyarthritis
P2860
Q26863359-63B41E50-511A-4219-9C56-BA092165D0E4Q27021438-81281D65-2C4E-4767-B014-95A95419C551Q30876263-EA9EE9C8-49D1-4E05-837B-902DCD9E2074Q33451953-C197939F-105A-4324-AB7D-CAA87553E7BCQ34092224-F248C61A-2049-42E2-9387-5EE4A8309486Q34343286-BA6DFF03-B764-40F5-AB9E-5E269DCF1A7CQ34413235-13BC0892-DC63-466B-92F9-94F49277920CQ34625994-9F51711D-5516-468A-84BF-DE6C4D9D3E76Q34992359-9C7DB8FC-86DA-4258-A79E-11E92A77EEE7Q35882730-72EDC2F1-4AA2-40AA-961E-D949A4C85BF7Q36519827-3CF7BC0A-2EDD-409C-A176-817845FB412EQ37676988-3996846A-A87B-45FE-BC2F-A0AFE3D8C540Q37704950-9E87064F-A303-496E-8D98-739456830D59Q37719255-E6248413-16E9-48FD-86F3-744E46611ADDQ37807993-43E1A33D-B03B-49C3-B8C8-81A36C01398BQ37927214-9C4CE227-1947-4B7E-BE13-B378CC64C509Q37959331-3AE028C6-975A-47A3-8D65-A4408944AA43Q37964579-AB4417FB-63AA-40BD-B8EB-C727E41B240BQ37997073-36B387F3-278D-4CED-96B0-3BC61E88EE70Q38001790-57CB76A6-256C-4B4E-B0AC-979358A2E7EAQ38065208-BC01E90C-3277-49ED-B439-23BA2AC44AC2Q38125456-42B57473-FE39-4ACE-8A4B-34C897EF4788Q38179461-71106B11-E77C-4A3A-A636-47116FDCA7CEQ38416698-03FB6AAA-7C97-4D8A-B2BC-90EE6ADD4F2FQ39181014-7D3AE0EA-B586-4102-86BE-A79ADE36C206Q40624064-13F105EC-0394-4868-AD1F-9353307A7DF7Q41005889-A3051815-6DE0-4E5A-9811-0FEA5E56EDF6Q41468717-78085B75-35A9-4FA8-8FDB-F1A8F331A827Q42870497-E9D64405-DE4F-4C05-9BAF-F741B57CA486Q44221482-5E2FAC1C-6C33-4B85-BE30-D5546A991B9FQ45254873-703F8149-301D-42DF-9FA5-7D3F9669D4EAQ46359872-BFA9FAC2-CD1F-4806-AB03-F81949E86B1CQ50082792-B0AE088D-4BB4-46FD-A20B-B907EB635F90Q50946132-E9046FA8-4044-4A91-A497-120F73B2FA28Q51841138-6DBFC3E7-DD40-43A1-86AB-BD78F6B4AD8DQ54968721-D8AD1A9C-41DF-4664-9F49-CF9A63058EE8Q55109378-4A208464-B6B0-4041-99C4-5C695EE07F68Q57231940-996FFBAC-0062-4FA9-828E-412DF3C13FC0
P2860
Prospective new biological therapies for rheumatoid arthritis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prospective new biological therapies for rheumatoid arthritis.
@en
Prospective new biological therapies for rheumatoid arthritis.
@nl
type
label
Prospective new biological therapies for rheumatoid arthritis.
@en
Prospective new biological therapies for rheumatoid arthritis.
@nl
prefLabel
Prospective new biological therapies for rheumatoid arthritis.
@en
Prospective new biological therapies for rheumatoid arthritis.
@nl
P50
P1433
P1476
Prospective new biological therapies for rheumatoid arthritis.
@en
P2093
Jirí Vencovský
Steffen Gay
P304
P356
10.1016/J.AUTREV.2009.03.010
P577
2009-03-26T00:00:00Z